BOSTON, June 2, 2022
/PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), the leading
horizontal platform for cell programming, announced today that
management is scheduled to participate in William Blair's 42nd Annual Growth
Stock Conference, on June 9, 2022, at
11:20 a.m. CT.
Further details, a webcast link, and a replay of the
presentation, if available, will be posted on the company's
investor relations website at
https://investors.ginkgobioworks.com/events.
About Ginkgo Bioworks
Ginkgo is building a platform to enable customers to program
cells as easily as we can program computers. The company's platform
is enabling biotechnology applications across diverse markets, from
food and agriculture to industrial chemicals to pharmaceuticals.
Ginkgo has also actively supported a number of COVID-19 response
efforts, including K-12 pooled testing, vaccine manufacturing
optimization, and therapeutics discovery. For more information,
visit www.ginkgobioworks.com.
Ginkgo Bioworks Contacts:
INVESTOR
CONTACT:
investors@ginkgobioworks.com
MEDIA CONTACT:
press@ginkgobioworks.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-participation-in-william-blairs-42nd-annual-growth-stock-conference-301560527.html
SOURCE Ginkgo Bioworks